Advice
Following an abbreviated submission
Brimonidine / timolol (Combigan) eye drops are accepted for use in NHS Scotland for the reduction of intra-ocular pressure in patients with chronic open-angle glaucoma or ocular hypertension who are insufficiently responsive to topical beta-blockers alone and for whom brimonidine is an appropriate choice of adjuvant therapy. The combination product may be associated with a modest decrease in cost compared with the individual components and allows patients to administer fewer drops.
Download detailed advice29KB (PDF)
Medicine details
- Medicine name:
- Brimonidine/timolol (Combigan®) eye drops
- SMC ID:
- 196/05
- Indication:
- Reduction of intra-ocular pressure in patients with chronic open-angle glaucoma or ocular hypertension
- Pharmaceutical company
- Allergan Ltd
- BNF chapter
- Eye
- Submission type
- Abbreviated
- Status
- Accepted
- Date advice published
- 12 September 2005